Global Clinical Trial Imaging 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI01241668

Publication Date:

January 11, 2024

Pages:

133

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Clinical Trial Imaging market size was valued at US$ 1343.5 million in 2023. With growing demand in downstream market, the Clinical Trial Imaging is forecast to a readjusted size of US$ 2184.2 million by 2030 with a CAGR of 7.2% during review period.
The research report highlights the growth potential of the global Clinical Trial Imaging market. Clinical Trial Imaging are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Clinical Trial Imaging. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Clinical Trial Imaging market.
Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.
Global core clinical trial imaging manufacturers include Clario, ICON, McLaren, Calyx and BioTelemetry. The top 5 companies hold a share about 60%. North America is the largest market, with a share about 33%, followed by Europe and Asia Pacific both with the share about 27%. In terms of product, central imaging service is the largest segment, with a share about 70%. And in terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.
Key Features:
The report on Clinical Trial Imaging market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Clinical Trial Imaging market. It may include historical data, market segmentation by Type (e.g., In-house Imaging Service, Central Imaging Service), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Clinical Trial Imaging market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Clinical Trial Imaging market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Clinical Trial Imaging industry. This include advancements in Clinical Trial Imaging technology, Clinical Trial Imaging new entrants, Clinical Trial Imaging new investment, and other innovations that are shaping the future of Clinical Trial Imaging.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Clinical Trial Imaging market. It includes factors influencing customer ' purchasing decisions, preferences for Clinical Trial Imaging product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Clinical Trial Imaging market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Clinical Trial Imaging market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Clinical Trial Imaging market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Clinical Trial Imaging industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Clinical Trial Imaging market.
麻豆原创 Segmentation:
Clinical Trial Imaging market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
In-house Imaging Service
Central Imaging Service
Segmentation by application
Pharmaceutical Companies
Biotechnology Companies
Academic Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
ICON
ERT
McLaren
Bioclinica
Parexel
BioTelemetry
ProScan Imaging
Imaging Endpoints
Radiant Sage
Micron, Inc.
Intrinsic Imaging
Median Technologies
Cardiovascular Imaging Technologies
Banook Medical
IXICO

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Clinical Trial Imaging 麻豆原创 Size 2019-2030
2.1.2 Clinical Trial Imaging 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Clinical Trial Imaging Segment by Type
2.2.1 In-house Imaging Service
2.2.2 Central Imaging Service
2.3 Clinical Trial Imaging 麻豆原创 Size by Type
2.3.1 Clinical Trial Imaging 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Clinical Trial Imaging 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Clinical Trial Imaging Segment by Application
2.4.1 Pharmaceutical Companies
2.4.2 Biotechnology Companies
2.4.3 Academic Institutes
2.4.4 Others
2.5 Clinical Trial Imaging 麻豆原创 Size by Application
2.5.1 Clinical Trial Imaging 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Clinical Trial Imaging 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Clinical Trial Imaging 麻豆原创 Size by Player
3.1 Clinical Trial Imaging 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Clinical Trial Imaging Revenue by Players (2019-2024)
3.1.2 Global Clinical Trial Imaging Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Clinical Trial Imaging Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Clinical Trial Imaging by Regions
4.1 Clinical Trial Imaging 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Clinical Trial Imaging 麻豆原创 Size Growth (2019-2024)
4.3 APAC Clinical Trial Imaging 麻豆原创 Size Growth (2019-2024)
4.4 Europe Clinical Trial Imaging 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Clinical Trial Imaging 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Clinical Trial Imaging 麻豆原创 Size by Country (2019-2024)
5.2 Americas Clinical Trial Imaging 麻豆原创 Size by Type (2019-2024)
5.3 Americas Clinical Trial Imaging 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Clinical Trial Imaging 麻豆原创 Size by Region (2019-2024)
6.2 APAC Clinical Trial Imaging 麻豆原创 Size by Type (2019-2024)
6.3 APAC Clinical Trial Imaging 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Clinical Trial Imaging by Country (2019-2024)
7.2 Europe Clinical Trial Imaging 麻豆原创 Size by Type (2019-2024)
7.3 Europe Clinical Trial Imaging 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Clinical Trial Imaging by Region (2019-2024)
8.2 Middle East & Africa Clinical Trial Imaging 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Clinical Trial Imaging 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Clinical Trial Imaging 麻豆原创 Forecast
10.1 Global Clinical Trial Imaging Forecast by Regions (2025-2030)
10.1.1 Global Clinical Trial Imaging Forecast by Regions (2025-2030)
10.1.2 Americas Clinical Trial Imaging Forecast
10.1.3 APAC Clinical Trial Imaging Forecast
10.1.4 Europe Clinical Trial Imaging Forecast
10.1.5 Middle East & Africa Clinical Trial Imaging Forecast
10.2 Americas Clinical Trial Imaging Forecast by Country (2025-2030)
10.2.1 United States Clinical Trial Imaging 麻豆原创 Forecast
10.2.2 Canada Clinical Trial Imaging 麻豆原创 Forecast
10.2.3 Mexico Clinical Trial Imaging 麻豆原创 Forecast
10.2.4 Brazil Clinical Trial Imaging 麻豆原创 Forecast
10.3 APAC Clinical Trial Imaging Forecast by Region (2025-2030)
10.3.1 China Clinical Trial Imaging 麻豆原创 Forecast
10.3.2 Japan Clinical Trial Imaging 麻豆原创 Forecast
10.3.3 Korea Clinical Trial Imaging 麻豆原创 Forecast
10.3.4 Southeast Asia Clinical Trial Imaging 麻豆原创 Forecast
10.3.5 India Clinical Trial Imaging 麻豆原创 Forecast
10.3.6 Australia Clinical Trial Imaging 麻豆原创 Forecast
10.4 Europe Clinical Trial Imaging Forecast by Country (2025-2030)
10.4.1 Germany Clinical Trial Imaging 麻豆原创 Forecast
10.4.2 France Clinical Trial Imaging 麻豆原创 Forecast
10.4.3 UK Clinical Trial Imaging 麻豆原创 Forecast
10.4.4 Italy Clinical Trial Imaging 麻豆原创 Forecast
10.4.5 Russia Clinical Trial Imaging 麻豆原创 Forecast
10.5 Middle East & Africa Clinical Trial Imaging Forecast by Region (2025-2030)
10.5.1 Egypt Clinical Trial Imaging 麻豆原创 Forecast
10.5.2 South Africa Clinical Trial Imaging 麻豆原创 Forecast
10.5.3 Israel Clinical Trial Imaging 麻豆原创 Forecast
10.5.4 Turkey Clinical Trial Imaging 麻豆原创 Forecast
10.5.5 GCC Countries Clinical Trial Imaging 麻豆原创 Forecast
10.6 Global Clinical Trial Imaging Forecast by Type (2025-2030)
10.7 Global Clinical Trial Imaging Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 ICON
11.1.1 ICON Company Information
11.1.2 ICON Clinical Trial Imaging Product Offered
11.1.3 ICON Clinical Trial Imaging Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 ICON Main Business Overview
11.1.5 ICON Latest Developments
11.2 ERT
11.2.1 ERT Company Information
11.2.2 ERT Clinical Trial Imaging Product Offered
11.2.3 ERT Clinical Trial Imaging Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 ERT Main Business Overview
11.2.5 ERT Latest Developments
11.3 McLaren
11.3.1 McLaren Company Information
11.3.2 McLaren Clinical Trial Imaging Product Offered
11.3.3 McLaren Clinical Trial Imaging Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 McLaren Main Business Overview
11.3.5 McLaren Latest Developments
11.4 Bioclinica
11.4.1 Bioclinica Company Information
11.4.2 Bioclinica Clinical Trial Imaging Product Offered
11.4.3 Bioclinica Clinical Trial Imaging Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Bioclinica Main Business Overview
11.4.5 Bioclinica Latest Developments
11.5 Parexel
11.5.1 Parexel Company Information
11.5.2 Parexel Clinical Trial Imaging Product Offered
11.5.3 Parexel Clinical Trial Imaging Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Parexel Main Business Overview
11.5.5 Parexel Latest Developments
11.6 BioTelemetry
11.6.1 BioTelemetry Company Information
11.6.2 BioTelemetry Clinical Trial Imaging Product Offered
11.6.3 BioTelemetry Clinical Trial Imaging Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 BioTelemetry Main Business Overview
11.6.5 BioTelemetry Latest Developments
11.7 ProScan Imaging
11.7.1 ProScan Imaging Company Information
11.7.2 ProScan Imaging Clinical Trial Imaging Product Offered
11.7.3 ProScan Imaging Clinical Trial Imaging Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 ProScan Imaging Main Business Overview
11.7.5 ProScan Imaging Latest Developments
11.8 Imaging Endpoints
11.8.1 Imaging Endpoints Company Information
11.8.2 Imaging Endpoints Clinical Trial Imaging Product Offered
11.8.3 Imaging Endpoints Clinical Trial Imaging Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Imaging Endpoints Main Business Overview
11.8.5 Imaging Endpoints Latest Developments
11.9 Radiant Sage
11.9.1 Radiant Sage Company Information
11.9.2 Radiant Sage Clinical Trial Imaging Product Offered
11.9.3 Radiant Sage Clinical Trial Imaging Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Radiant Sage Main Business Overview
11.9.5 Radiant Sage Latest Developments
11.10 Micron, Inc.
11.10.1 Micron, Inc. Company Information
11.10.2 Micron, Inc. Clinical Trial Imaging Product Offered
11.10.3 Micron, Inc. Clinical Trial Imaging Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Micron, Inc. Main Business Overview
11.10.5 Micron, Inc. Latest Developments
11.11 Intrinsic Imaging
11.11.1 Intrinsic Imaging Company Information
11.11.2 Intrinsic Imaging Clinical Trial Imaging Product Offered
11.11.3 Intrinsic Imaging Clinical Trial Imaging Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Intrinsic Imaging Main Business Overview
11.11.5 Intrinsic Imaging Latest Developments
11.12 Median Technologies
11.12.1 Median Technologies Company Information
11.12.2 Median Technologies Clinical Trial Imaging Product Offered
11.12.3 Median Technologies Clinical Trial Imaging Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 Median Technologies Main Business Overview
11.12.5 Median Technologies Latest Developments
11.13 Cardiovascular Imaging Technologies
11.13.1 Cardiovascular Imaging Technologies Company Information
11.13.2 Cardiovascular Imaging Technologies Clinical Trial Imaging Product Offered
11.13.3 Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 Cardiovascular Imaging Technologies Main Business Overview
11.13.5 Cardiovascular Imaging Technologies Latest Developments
11.14 Banook Medical
11.14.1 Banook Medical Company Information
11.14.2 Banook Medical Clinical Trial Imaging Product Offered
11.14.3 Banook Medical Clinical Trial Imaging Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 Banook Medical Main Business Overview
11.14.5 Banook Medical Latest Developments
11.15 IXICO
11.15.1 IXICO Company Information
11.15.2 IXICO Clinical Trial Imaging Product Offered
11.15.3 IXICO Clinical Trial Imaging Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.15.4 IXICO Main Business Overview
11.15.5 IXICO Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.